XML 22 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Comprehensive Loss - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Net loss $ (7,884,770) $ (17,158,017) $ (19,932,566) $ (36,389,505)
Available for sale securities - net unrealized (loss) gain 0 1,866 (486) 537
Total other comprehensive loss 0 1,866 (486) 537
Comprehensive loss (7,884,770) (17,156,151) (19,933,052) (36,388,968)
Comprehensive loss attributable to noncontrolling interests (50,054) (31,757) (116,933) (76,349)
Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders $ (7,834,716) $ (17,124,394) $ (19,816,119) $ (36,312,619)